MTOR and renal cell carcinoma: Numerous studies have demonstrated that miRNAs, including miR‐148a, miR‐182‐5p, and miR‐137, can inhibit the PI3K/AKT/mTOR pathway, consequently suppressing the proliferation, migration, and invasive capabilities of RCC cells.36